<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459914</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Construction and Immunogenicity of a Recombinant Porcine Pseudorabies Virus (PRV) Expressing the Major Neutralizing Epitope Regions of S1 Protein of Variant PEDV.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1580</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16101580</ELocationID><Abstract><AbstractText>Porcine epidemic diarrhea virus (PEDV) infection causes severe diarrhea and high mortality in neonatal piglets. Pseudorabies causes acute and often fatal infections in young piglets, respiratory disorders in growing pigs, and reproductive failure in sows. In late 2011, pseudorabies virus (PRV) variants occurred in Bartha-K61-vaccine-immunized swine herds, resulting in economic losses to the global pig industry. Therefore, it is essential to develop a safe and effective vaccine against both PEDV and PRV infections. In this study, we constructed a recombinant virus rPRV-PEDV S1 expressing the major neutralizing epitope region (COE, SS2, and SS6) of the PEDV S1 protein by homologous recombination technology and CRISPR/Cas9 gene editing technology, and then evaluated its biological characteristics in vitro and immunogenicity in pigs. The recombinant virus rPRV-PEDV S1 had similar growth kinetics in vitro to the parental rPRV NY-gE<sup>-</sup>/gI<sup>-</sup>/TK<sup>-</sup> strain, and was proven genetically stable in swine testicle (ST) cells and safe for piglets. PEDV S1-specific antibodies were detected in piglets immunized with rPRV-PEDV S1 on the 7th day post-immunization (dpi), and the antibody level increased rapidly at 14-21 dpi. Moreover, the immunized piglets receiving the recombinant virus exhibited alleviated clinical signs and reduced viral load compared to the unvaccinated group following a virulent PEDV HN2021 strain challenge. Also, piglets immunized with rPRV-PEDV S1 developed a PRV-specific humoral immune response and elicited complete protection against a lethal PRV NY challenge. These data indicate that the recombinant rPRV-PEDV S1 is a promising vaccine candidate strain for the prevention and control of PEDV and PRV infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Xian-Qin</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xi-Meng</ForeName><Initials>XM</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Cheng-Yuan</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Jian-Tao</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Animal Health Supervision Institute, Honghu 433200, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Lan-Lan</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Shi-Jie</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hong-Ying</ForeName><Initials>HY</Initials><Identifier Source="ORCID">0000-0002-8245-3999</Identifier><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053485" MajorTopicYN="Y">Porcine epidemic diarrhea virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011558" MajorTopicYN="Y">Herpesvirus 1, Suid</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013553" MajorTopicYN="Y">Swine Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="Y">Epitopes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="Y">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011557" MajorTopicYN="N">Pseudorabies</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">porcine epidemic diarrhea virus</Keyword><Keyword MajorTopicYN="N">porcine pseudorabies virus</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459914</ArticleId><ArticleId IdType="pmc">PMC11512226</ArticleId><ArticleId IdType="doi">10.3390/v16101580</ArticleId><ArticleId IdType="pii">v16101580</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pensaert M.B., de Bouck P. A new coronavirus-like particle associated with diarrhea in swine. Arch. Virol. 1978;58:243–247. doi: 10.1007/BF01317606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317606</ArticleId><ArticleId IdType="pmc">PMC7086830</ArticleId><ArticleId IdType="pubmed">83132</ArticleId></ArticleIdList></Reference><Reference><Citation>Debouck P., Pensaert M. Experimental infection of pigs with a new porcine enteric coronavirus, CV 777. Am. J. Vet. Res. 1980;41:219–223.</Citation><ArticleIdList><ArticleId IdType="pubmed">6245603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensaert M.B., Martelli P. Porcine epidemic diarrhea: A retrospect from Europe and matters of debate. Virus Res. 2016;226:1–6. doi: 10.1016/j.virusres.2016.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.05.030</ArticleId><ArticleId IdType="pmc">PMC7132433</ArticleId><ArticleId IdType="pubmed">27317168</ArticleId></ArticleIdList></Reference><Reference><Citation>Antas M., Woźniakowski G. Current Status of Porcine Epidemic Diarrhoea (PED) in European Pigs. J. Vet. Res. 2019;63:465–470. doi: 10.2478/jvetres-2019-0064.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/jvetres-2019-0064</ArticleId><ArticleId IdType="pmc">PMC6950429</ArticleId><ArticleId IdType="pubmed">31934654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wang C., Shi H., Qiu H., Liu S., Chen X., Zhang Z., Feng L. Molecular epidemiology of porcine epidemic diarrhea virus in China. Arch. Virol. 2010;155:1471–1476. doi: 10.1007/s00705-010-0720-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-010-0720-2</ArticleId><ArticleId IdType="pmc">PMC7086990</ArticleId><ArticleId IdType="pubmed">20544234</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.F., Sun D.B., Wang C.B., Shi H.Y., Cui X.C., Liu S.W., Qiu H.J., Feng L. Molecular characterization and phylogenetic analysis of membrane protein genes of porcine epidemic diarrhea virus isolates in China. Virus Genes. 2008;36:355–364. doi: 10.1007/s11262-007-0196-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-007-0196-7</ArticleId><ArticleId IdType="pmc">PMC7088904</ArticleId><ArticleId IdType="pubmed">18214664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Liu X., Shi D., Shi H., Zhang X., Feng L. Complete genome sequence of a porcine epidemic diarrhea virus variant. J. Virol. 2012;86:3408. doi: 10.1128/JVI.07150-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.07150-11</ArticleId><ArticleId IdType="pmc">PMC3302349</ArticleId><ArticleId IdType="pubmed">22354946</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Liu X., Shi D., Shi H., Zhang X., Li C., Chi Y., Feng L. Detection and molecular diversity of spike gene of porcine epidemic diarrhea virus in China. Viruses. 2013;5:2601–2613. doi: 10.3390/v5102601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v5102601</ArticleId><ArticleId IdType="pmc">PMC3814607</ArticleId><ArticleId IdType="pubmed">24153062</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wang C., Shi H., Qiu H.J., Liu S., Shi D., Zhang X., Feng L. Complete genome sequence of a Chinese virulent porcine epidemic diarrhea virus strain. J. Virol. 2011;85:11538–11539. doi: 10.1128/JVI.06024-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06024-11</ArticleId><ArticleId IdType="pmc">PMC3194942</ArticleId><ArticleId IdType="pubmed">21980030</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Li H., Liu Y., Pan Y., Deng F., Song Y., Tang X., He Q. New variants of porcine epidemic diarrhea virus, China, 2011. Emerg. Infect Dis. 2012;18:1350–1353. doi: 10.3201/eid1803.120002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1803.120002</ArticleId><ArticleId IdType="pmc">PMC3414035</ArticleId><ArticleId IdType="pubmed">22840964</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z.L., Zhu L., Ma J.Y., Zhou Q.F., Song Y.H., Sun B.L., Chen R.A., Xie Q.M., Bee Y.Z. Molecular characterization and phylogenetic analysis of porcine epidemic diarrhea virus (PEDV) field strains in south China. Virus Genes. 2012;45:181–185. doi: 10.1007/s11262-012-0735-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-012-0735-8</ArticleId><ArticleId IdType="pubmed">22528639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Wang M., Zhou J., Feng L. Adaptation of porcine epidemic diarrhea virus to Vero cells and evaluation of the inactivated vaccine against porcine epidemic diarrhea virus. Chin. Anim. Infect. Dis. 1994;2:15–18.</Citation></Reference><Reference><Citation>Ma S.Q., Wang M., Feng L., Li W. Development of bi-combined inactivated vaccine against transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Chin. Anim. Infect. Dis. 1995;17:23–27.</Citation></Reference><Reference><Citation>Tong Y., Feng L., Li W. Development of bi-combined attenuated vaccine against transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Chin. J. Prev. Vet. Med. 1999;21:406–410.</Citation></Reference><Reference><Citation>Sun D., Wang X., Wei S., Chen J., Feng L. Epidemiology and vaccine of porcine epidemic diarrhea virus in China: A mini-review. J. Vet. Med. Sci. 2016;78:355–363. doi: 10.1292/jvms.15-0446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.15-0446</ArticleId><ArticleId IdType="pmc">PMC4829501</ArticleId><ArticleId IdType="pubmed">26537549</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Ma Z., Li Y., Gao S., Xiao S. Porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and vaccines. Microb. Pathog. 2020;149:104553. doi: 10.1016/j.micpath.2020.104553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2020.104553</ArticleId><ArticleId IdType="pmc">PMC7527827</ArticleId><ArticleId IdType="pubmed">33011361</ArticleId></ArticleIdList></Reference><Reference><Citation>Murtaza A., Hoa N.T., Dieu-Huong D., Afzal H., Tariq M.H., Cheng L.T., Chung Y.C. Advancing PEDV Vaccination: Comparison between Inactivated and Flagellin N-Terminus-Adjuvanted Subunit Vaccines. Vaccines. 2024;12:139. doi: 10.3390/vaccines12020139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12020139</ArticleId><ArticleId IdType="pmc">PMC10892538</ArticleId><ArticleId IdType="pubmed">38400123</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.H., Yang D.K., Kim H.H., Cho I.S. Efficacy of inactivated variant porcine epidemic diarrhea virus vaccines in growing pigs. Clin. Exp. Vaccine Res. 2018;7:61–69. doi: 10.7774/cevr.2018.7.1.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2018.7.1.61</ArticleId><ArticleId IdType="pmc">PMC5795046</ArticleId><ArticleId IdType="pubmed">29399581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocherhans R., Bridgen A., Ackermann M., Tobler K. Completion of the porcine epidemic diarrhoea coronavirus (PEDV) genome sequence. Virus Genes. 2001;23:137–144. doi: 10.1023/A:1011831902219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1011831902219</ArticleId><ArticleId IdType="pmc">PMC7089135</ArticleId><ArticleId IdType="pubmed">11724265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Li G., Stasko J., Thomas J.T., Stensland W.R., Pillatzki A.E., Gauger P.C., Schwartz K.J., Madson D., Yoon K.J., et al. Isolation and characterization of porcine epidemic diarrhea viruses associated with the 2013 disease outbreak among swine in the United States. J. Clin. Microbiol. 2014;52:234–243. doi: 10.1128/JCM.02820-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02820-13</ArticleId><ArticleId IdType="pmc">PMC3911415</ArticleId><ArticleId IdType="pubmed">24197882</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian P.F., Jin Y.L., Xing G., Qv L.L., Huang Y.W., Zhou J.Y. Evidence of recombinant strains of porcine epidemic diarrhea virus, United States, 2013. Emerg. Infect. Dis. 2014;20:1735–1738. doi: 10.3201/eid2010.140338.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2010.140338</ArticleId><ArticleId IdType="pmc">PMC4193173</ArticleId><ArticleId IdType="pubmed">25272273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.K., Park C.K., Kim S.H., Lee C. Heterogeneity in spike protein genes of porcine epidemic diarrhea viruses isolated in Korea. Virus Res. 2010;149:175–182. doi: 10.1016/j.virusres.2010.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2010.01.015</ArticleId><ArticleId IdType="pmc">PMC7114470</ArticleId><ArticleId IdType="pubmed">20132850</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Xie X., Yang L., Wang A. A Comprehensive View on the Host Factors and Viral Proteins Associated With Porcine Epidemic Diarrhea Virus Infection. Front. Microbiol. 2021;12:762358. doi: 10.3389/fmicb.2021.762358.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.762358</ArticleId><ArticleId IdType="pmc">PMC8688245</ArticleId><ArticleId IdType="pubmed">34950116</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Li W., Lucio de Esesarte E., Guo H., van den Elzen P., Aarts E., van den Born E., Rottier P.J.M., Bosch B.J. Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies. J. Virol. 2017;91:e00273-17. doi: 10.1128/JVI.00273-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00273-17</ArticleId><ArticleId IdType="pmc">PMC5446644</ArticleId><ArticleId IdType="pubmed">28381581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.Y., Cheng I.C., Chang Y.C., Tsai P.S., Lai S.Y., Huang Y.L., Jeng C.R., Pang V.F., Chang H.W. Identification of Neutralizing Monoclonal Antibodies Targeting Novel Conformational Epitopes of the Porcine Epidemic Diarrhoea Virus Spike Protein. Sci. Rep. 2019;9:2529. doi: 10.1038/s41598-019-39844-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39844-5</ArticleId><ArticleId IdType="pmc">PMC6385244</ArticleId><ArticleId IdType="pubmed">30792462</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S.H., Bae J.L., Kang T.J., Kim J., Chung G.H., Lim C.W., Laude H., Yang M.S., Jang Y.S. Identification of the epitope region capable of inducing neutralizing antibodies against the porcine epidemic diarrhea virus. Mol. Cells. 2002;14:295–299. doi: 10.1016/S1016-8478(23)15106-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1016-8478(23)15106-5</ArticleId><ArticleId IdType="pubmed">12442904</ArticleId></ArticleIdList></Reference><Reference><Citation>Okda F.A., Lawson S., Singrey A., Nelson J., Hain K.S., Joshi L.R., Christopher-Hennings J., Nelson E.A., Diel D.G. The S2 glycoprotein subunit of porcine epidemic diarrhea virus contains immunodominant neutralizing epitopes. Virology. 2017;509:185–194. doi: 10.1016/j.virol.2017.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.06.013</ArticleId><ArticleId IdType="pmc">PMC7111671</ArticleId><ArticleId IdType="pubmed">28647506</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz D.J., Kim C.J., Shin H.J. The GPRLQPY motif located at the carboxy-terminal of the spike protein induces antibodies that neutralize Porcine epidemic diarrhea virus. Virus Res. 2008;132:192–196. doi: 10.1016/j.virusres.2007.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2007.10.015</ArticleId><ArticleId IdType="pmc">PMC7114191</ArticleId><ArticleId IdType="pubmed">18067984</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D., Feng L., Shi H., Chen J., Cui X., Chen H., Liu S., Tong Y., Wang Y., Tong G. Identification of two novel B cell epitopes on porcine epidemic diarrhea virus spike protein. Vet. Microbiol. 2008;131:73–81. doi: 10.1016/j.vetmic.2008.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2008.02.022</ArticleId><ArticleId IdType="pmc">PMC7117171</ArticleId><ArticleId IdType="pubmed">18400422</ArticleId></ArticleIdList></Reference><Reference><Citation>Klupp B.G., Hengartner C.J., Mettenleiter T.C., Enquist L.W. Complete, annotated sequence of the pseudorabies virus genome. J. Virol. 2004;78:424–440. doi: 10.1128/JVI.78.1.424-440.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.1.424-440.2004</ArticleId><ArticleId IdType="pmc">PMC303424</ArticleId><ArticleId IdType="pubmed">14671123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimman T.G., de Wind N., Oei-Lie N., Pol J.M., Berns A.J., Gielkens A.L. Contribution of single genes within the unique short region of Aujeszky’s disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. J. Gen. Virol. 1992;73:243–251. doi: 10.1099/0022-1317-73-2-243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-73-2-243</ArticleId><ArticleId IdType="pubmed">1311354</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Luo Y., Wang C.H., Yuan J., Li N., Song K., Qiu H.J. Control of swine pseudorabies in China: Opportunities and limitations. Vet. Microbiol. 2016;183:119–124. doi: 10.1016/j.vetmic.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2015.12.008</ArticleId><ArticleId IdType="pubmed">26790944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Li S., Wang X., Zou M., Gao S. Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus. Vaccine. 2017;35:1161–1166. doi: 10.1016/j.vaccine.2017.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.01.003</ArticleId><ArticleId IdType="pubmed">28131396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju C., Fan H., Tan Y., Liu Z., Xi X., Cao S., Wu B., Chen H. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Vet. Microbiol. 2005;109:179–190. doi: 10.1016/j.vetmic.2005.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2005.06.001</ArticleId><ArticleId IdType="pubmed">16006077</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Fang L., Xiao S., Zhang H., Pan Y., Luo R., Li B., Chen H. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Vaccine. 2007;25:547–560. doi: 10.1016/j.vaccine.2006.07.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2006.07.032</ArticleId><ArticleId IdType="pubmed">16920232</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie H., Fang R., Xiong B.Q., Wang L.X., Hu M., Zhou Y.Q., Zhao J.L. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins. Vet. Parasitol. 2011;181:215–221. doi: 10.1016/j.vetpar.2011.04.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetpar.2011.04.039</ArticleId><ArticleId IdType="pubmed">21632181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H.H., Wang L.Q., Fu P.F., Zheng L.L., Chen H.Y., Liu F. Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6. Virol. J. 2020;17:19. doi: 10.1186/s12985-020-1292-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-1292-8</ArticleId><ArticleId IdType="pmc">PMC6998180</ArticleId><ArticleId IdType="pubmed">32014014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y.Y., Liu K.S., Zhang C., Ni Z., Zhu Y.C., Bao H.L., Chen L., Ye W.C., Hua J.G., Huo S.X., et al. Recombinant pseudorabies virus (PRV) expressing stabilized E2 of classical swine fever virus (CSFV) protects against both PRV and CSFV. Antivir. Res. 2023;211:105548. doi: 10.1016/j.antiviral.2023.105548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2023.105548</ArticleId><ArticleId IdType="pubmed">36702445</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Xu Z., Gu S., Nie M., Wang Y., Zhao J., Li F., Deng H., Huang J., Sun X., et al. The recombinant pseudorabies virus expressing porcine deltacoronavirus spike protein is safe and effective for mice. BMC Vet. Res. 2022;18:16. doi: 10.1186/s12917-021-03115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12917-021-03115-1</ArticleId><ArticleId IdType="pmc">PMC8725529</ArticleId><ArticleId IdType="pubmed">34983523</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R.Q., Wang L.Q., Zheng H.H., Tian R.B., Zheng L.L., Ma S.J., Chen H.Y. Characterization of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the Cap protein of porcine circovirus type 2d. Comp. Immunol. Microbiol. Infect. Dis. 2023;101:102054. doi: 10.1016/j.cimid.2023.102054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cimid.2023.102054</ArticleId><ArticleId IdType="pubmed">37651789</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Q., Zhu L., Xu L., Yang Y., Zhang Y., Liu Z., Xu T., Wen J., Deng L., Zhou Y., et al. The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression. Microbiol. Spectr. 2023;11:e0522922. doi: 10.1128/spectrum.05229-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.05229-22</ArticleId><ArticleId IdType="pmc">PMC10100989</ArticleId><ArticleId IdType="pubmed">36976021</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.H., Li H.X., Chen X.M., Zhang L.H., Zhao Y.Y., Luo A.F., Yang Y.R., Zheng L.L., Chen H.Y. Genetic Characteristics and Pathogenicity of a Novel Porcine Epidemic Diarrhea Virus with a Naturally Occurring Truncated ORF3 Gene. Viruses. 2022;14:487. doi: 10.3390/v14030487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030487</ArticleId><ArticleId IdType="pmc">PMC8955810</ArticleId><ArticleId IdType="pubmed">35336894</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Wang L.Q., Zheng H.H., Yang Y.R., Liu F., Zheng L.L., Jin Y., Chen H.Y. Construction and immunogenicity of a gE/gI/TK-deleted PRV based on porcine pseudorabies virus variant. Mol. Cell. Probes. 2020;53:101605. doi: 10.1016/j.mcp.2020.101605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcp.2020.101605</ArticleId><ArticleId IdType="pubmed">32464159</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L.L., Guo X.Q., Zhu Q.L., Chao A.J., Fu P.F., Wei Z.Y., Wang S.J., Chen H.Y., Cui B.A. Construction and immunogenicity of a recombinant pseudorabies virus co-expressing porcine circovirus type 2 capsid protein and interleukin 18. Virus Res. 2015;201:8–15. doi: 10.1016/j.virusres.2015.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.02.010</ArticleId><ArticleId IdType="pubmed">25701744</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed L.J., Muench H. A Simple Method Of Estimating Fifty Per Cent Endpoints12. Am. J. Epidemiol. 1938;27:493–497. doi: 10.1093/oxfordjournals.aje.a118408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H.Y., Zheng H.H., Zhao Y., Tian R.B., Xu P.L., Hou H.L., Chen H.Y., Yang M.F. Development of a SYBR green I-based duplex real-time fluorescence quantitative PCR assay for the simultaneous detection of porcine epidemic diarrhea virus and porcine circovirus 3. Mol. Cell. Probes. 2019;44:44–50. doi: 10.1016/j.mcp.2019.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcp.2019.02.002</ArticleId><ArticleId IdType="pmc">PMC7172278</ArticleId><ArticleId IdType="pubmed">30735700</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J.C., Ye C., Zhao K. Development of a SYBR Green I real-time PCR for detection ofgB gene of pseudorabies virus in swine. Chin. Vet. Sci. 2015;45:1166–1170. doi: 10.16656/j.issn.1673-4696.2015.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.16656/j.issn.1673-4696.2015.11.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson G.W., Hoang H., Schwartz K.J., Burrough E.R., Sun D., Madson D., Cooper V.L., Pillatzki A., Gauger P., Schmitt B.J., et al. Emergence of Porcine epidemic diarrhea virus in the United States: Clinical signs, lesions, and viral genomic sequences. J. Vet. Diagn. Investig. Off. Publ. Am. Assoc. Vet. Lab. Diagn. Inc. 2013;25:649–654. doi: 10.1177/1040638713501675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1040638713501675</ArticleId><ArticleId IdType="pubmed">23963154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Byrum B., Zhang Y. Detection and genetic characterization of deltacoronavirus in pigs, Ohio, USA, 2014. Emerg. Infect. Dis. 2014;20:1227–1230. doi: 10.3201/eid2007.140296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2007.140296</ArticleId><ArticleId IdType="pmc">PMC4073853</ArticleId><ArticleId IdType="pubmed">24964136</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung K., Saif L.J., Wang Q. Porcine epidemic diarrhea virus (PEDV): An update on etiology, transmission, pathogenesis, and prevention and control. Virus Res. 2020;286:198045. doi: 10.1016/j.virusres.2020.198045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198045</ArticleId><ArticleId IdType="pmc">PMC7266596</ArticleId><ArticleId IdType="pubmed">32502552</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanke D., Pohlmann A., Sauter-Louis C., Höper D., Stadler J., Ritzmann M., Steinrigl A., Schwarz B.A., Akimkin V., Fux R., et al. Porcine Epidemic Diarrhea in Europe: In-Detail Analyses of Disease Dynamics and Molecular Epidemiology. Viruses. 2017;9:177. doi: 10.3390/v9070177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9070177</ArticleId><ArticleId IdType="pmc">PMC5537669</ArticleId><ArticleId IdType="pubmed">28684708</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.W., Dickerman A.W., Piñeyro P., Li L., Fang L., Kiehne R., Opriessnig T., Meng X.J. Origin, evolution, and genotyping of emergent porcine epidemic diarrhea virus strains in the United States. mBio. 2013;4:e00737-13. doi: 10.1128/mBio.00737-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00737-13</ArticleId><ArticleId IdType="pmc">PMC3812708</ArticleId><ArticleId IdType="pubmed">24129257</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauring A.S., Jones J.O., Andino R. Rationalizing the development of live attenuated virus vaccines. Nat. Biotechnol. 2010;28:573–579. doi: 10.1038/nbt.1635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1635</ArticleId><ArticleId IdType="pmc">PMC2883798</ArticleId><ArticleId IdType="pubmed">20531338</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong C.Y., Ong H.K., Yeap S.K., Ho K.L., Tan W.S. Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus. Front. Microbiol. 2019;10:1781. doi: 10.3389/fmicb.2019.01781.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01781</ArticleId><ArticleId IdType="pmc">PMC6688523</ArticleId><ArticleId IdType="pubmed">31428074</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.E. Porcine Epidemic Diarrhea: Insights and Progress on Vaccines. Vaccines. 2024;12:212. doi: 10.3390/vaccines12020212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12020212</ArticleId><ArticleId IdType="pmc">PMC10892315</ArticleId><ArticleId IdType="pubmed">38400195</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Xu Z., Wu T., Peng O., Huang L., Zhang Y., Xue C., Wen Z., Zhou Q., Cao Y. A flagellin-adjuvanted PED subunit vaccine improved protective efficiency against PEDV variant challenge in pigs. Vaccine. 2018;36:4228–4235. doi: 10.1016/j.vaccine.2018.05.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.05.124</ArticleId><ArticleId IdType="pubmed">29891346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Clark-Deener S., Gillam F., Heffron C.L., Tian D., Sooryanarain H., LeRoith T., Zoghby J., Henshaw M., Waldrop S., et al. Virus-like particle vaccine with B-cell epitope from porcine epidemic diarrhea virus (PEDV) incorporated into hepatitis B virus core capsid provides clinical alleviation against PEDV in neonatal piglets through lactogenic immunity. Vaccine. 2020;38:5212–5218. doi: 10.1016/j.vaccine.2020.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.06.009</ArticleId><ArticleId IdType="pubmed">32565343</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardi N., Hogan M.J., Porter F.W., Weissman D. mRNA vaccines—A new era in vaccinology. Nat. Rev. Drug Discov. 2018;17:261–279. doi: 10.1038/nrd.2017.243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2017.243</ArticleId><ArticleId IdType="pmc">PMC5906799</ArticleId><ArticleId IdType="pubmed">29326426</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert. Rev. Vaccines. 2016;15:313–329. doi: 10.1586/14760584.2016.1124762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1124762</ArticleId><ArticleId IdType="pmc">PMC4955855</ArticleId><ArticleId IdType="pubmed">26707950</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F., Ren Y., Suo S., Sun X., Li X., Li P., Yang W., Li G., Li L., Schwegmann-Wessels C., et al. Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing spike genes from porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus. PLoS ONE. 2013;8:e57468. doi: 10.1371/journal.pone.0057468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057468</ArticleId><ArticleId IdType="pmc">PMC3602451</ArticleId><ArticleId IdType="pubmed">23526943</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhang X., Liao X., Huang X., Cao S., Wen X., Wen Y., Wu R., Liu W. Construction of a bivalent DNA vaccine co-expressing S genes of transmissible gastroenteritis virus and porcine epidemic diarrhea virus delivered by attenuated Salmonella typhimurium. Virus Genes. 2016;52:354–364. doi: 10.1007/s11262-016-1316-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-016-1316-z</ArticleId><ArticleId IdType="pubmed">26980672</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Fan B., Song X., Gao J., Guo R., Yi C., He Z., Hu H., Jiang J., Zhao L., et al. PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge. mBio. 2024;15:e0295823. doi: 10.1128/mbio.02958-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02958-23</ArticleId><ArticleId IdType="pmc">PMC10865985</ArticleId><ArticleId IdType="pubmed">38231557</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong X., Lei J.L., Xia S.L., Wang Y.M., Li Y., Li S., Luo Y., Sun Y., Qiu H.J. Pathogenicity and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant in susceptible animals. Vet. Microbiol. 2016;182:170–177. doi: 10.1016/j.vetmic.2015.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2015.11.022</ArticleId><ArticleId IdType="pubmed">26711045</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H.J., Tian Z.J., Tong G.Z., Zhou Y.J., Ni J.Q., Luo Y.Z., Cai X.H. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet. Immunol. Immunopathol. 2005;106:309–319. doi: 10.1016/j.vetimm.2005.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2005.03.008</ArticleId><ArticleId IdType="pubmed">15963827</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Guo W., Xu Z., Yan Q., Luo Y., Shi Q., Chen D., Zhu L., Wang X. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine. Virol. J. 2011;8:307. doi: 10.1186/1743-422X-8-307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-307</ArticleId><ArticleId IdType="pmc">PMC3130695</ArticleId><ArticleId IdType="pubmed">21679423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Huang J., Wang Q., He Y., Xu Z., Xiang M., Wu B., Chen H. Recombinant pseudorabies virus expressing P12A and 3C of FMDV can partially protect piglets against FMDV challenge. Res. Vet. Sci. 2011;91:90–94. doi: 10.1016/j.rvsc.2010.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rvsc.2010.09.001</ArticleId><ArticleId IdType="pubmed">20947111</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J., Lee K.W., Choi H.W., Lee C. Immunogenicity and protective efficacy of recombinant S1 domain of the porcine epidemic diarrhea virus spike protein. Arch. Virol. 2014;159:2977–2987. doi: 10.1007/s00705-014-2163-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-014-2163-7</ArticleId><ArticleId IdType="pmc">PMC7086977</ArticleId><ArticleId IdType="pubmed">25008896</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H., Liang Z., Lin J., Wang Y., Liu Y., Mei K., Zhao M., Huang S. Research progress of porcine epidemic diarrhea virus S protein. Front. Microbiol. 2024;15:1396894. doi: 10.3389/fmicb.2024.1396894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2024.1396894</ArticleId><ArticleId IdType="pmc">PMC11169810</ArticleId><ArticleId IdType="pubmed">38873162</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J.L., Xia S.L., Wang Y., Du M., Xiang G.T., Cong X., Luo Y., Li L.F., Zhang L., Yu J., et al. Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs. Immunol. Lett. 2016;174:63–71. doi: 10.1016/j.imlet.2016.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2016.04.014</ArticleId><ArticleId IdType="pubmed">27113530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Abid M., Cao S., Zhu S. Recombinant Pseudorabies Virus Usage in Vaccine Development against Swine Infectious Disease. Viruses. 2023;15:370. doi: 10.3390/v15020370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020370</ArticleId><ArticleId IdType="pmc">PMC9962541</ArticleId><ArticleId IdType="pubmed">36851584</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>